León-Román Francisco, Pintado-Cort Beatriz, Barberà Joan Albert, Sellares Jacobo, Iturbe David, López-Zubizarreta Marco, Peña-Miguel Teresa, Durán-Barata Diego, Jiménez David
Servicio de Neumología, Hospital Recoletas Salud Campo Grande, Valladolid, España.
Servicio de Neumología, Hospital Clinic, Barcelona, España.
Open Respir Arch. 2025 Feb 6;7(1):100406. doi: 10.1016/j.opresp.2025.100406. eCollection 2025 Jan-Mar.
Pulmonary embolism (PE) and pulmonary hypertension (PH) are common comorbidities that worsen the prognosis of patients diagnosed with interstitial lung disease (ILD). Despite advances in the diagnosis and treatment of these entities, their impact on the management and progression of ILD is not sufficiently studied. This article includes a review and update of the diagnosis and treatment of PE and PH in patients with underlying ILD.
肺栓塞(PE)和肺动脉高压(PH)是常见的合并症,会使被诊断为间质性肺疾病(ILD)的患者预后恶化。尽管在这些疾病的诊断和治疗方面取得了进展,但它们对ILD的管理和进展的影响尚未得到充分研究。本文包括对合并ILD患者的PE和PH诊断与治疗的综述及更新。